Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Maria Donata BENEDETTI"'
Autor:
Alberto Gajofatto, Nicolò Cardobi, Francesca Gobbin, Massimiliano Calabrese, Marco Turatti, Maria Donata Benedetti
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Nabiximols (Sativex®) is a cannabinoid approved for multiple sclerosis (MS)-related spasticity. Its mechanism of action is partially understood, and efficacy is variable. Objective To conduct an exploratory analysis of brain netw
Externí odkaz:
https://doaj.org/article/1ddb7b989ded4cc9ad61d42fa62670f5
Autor:
Marialuisa Gandolfi, Nicola Valè, Eleonora Kirilova Dimitrova, Stefano Mazzoleni, Elena Battini, Maria Donata Benedetti, Alberto Gajofatto, Francesco Ferraro, Matteo Castelli, Maruo Camin, Mirko Filippetti, Carola De Paoli, Elena Chemello, Alessandro Picelli, Jessica Corradi, Andreas Waldner, Leopold Saltuari, Nicola Smania
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
Background : Integration of robotics and upper limb rehabilitation in people with multiple sclerosis (PwMS) has rarely been investigated.Objective: To compare the effects of robot-assisted hand training against non-robotic hand training on upper limb
Externí odkaz:
https://doaj.org/article/0791b47d8dd847f5911f74c37641276a
Autor:
Sara Mariotto, Stefano Tamburin, Alessandro Salviati, Sergio Ferrari, Marco Zoccarato, Bruno Giometto, Laura Bertolasi, Franco Alessandrini, Maria Donata Benedetti, Salvatore Monaco
Publikováno v:
Case Reports in Neurology, Vol 6, Iss 1, Pp 38-43 (2014)
Background: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a rapidly evolving condition that combines psychiatric and neurologic manifestations. Much remains unclear about its clinical onset and subsequent course. Although successful
Externí odkaz:
https://doaj.org/article/c7c38502bb634610bd5748edb0ab18c2
Autor:
Rosanna Asselta, Nadia Barizzone, Maurizio Leone, Alessandro Salviati, Giulia Zeri, Maria Donata Benedetti, Donato Gemmati, Elisa Orioli, Elvezia Maria Paraboschi, Stefano Duga, Giulia Soldà
Publikováno v:
International Journal of Molecular Sciences, Vol 12, Iss 12, Pp 8695-8712 (2011)
Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system characterized by chronic inflammation, demyelination, and axonal damage. As microRNA (miRNA)-dependent alterations in gene expression in hematopoietic cells are cri
Externí odkaz:
https://doaj.org/article/9c5f474f465c46be88281c8fa1344160
Autor:
Salvatore Monaco, Maria Donata Benedetti, Gianluigi Zanusso, Alberto Gajofatto, Matilde Bongianni
Publikováno v:
International Journal of Molecular Sciences, Vol 12, Iss 11, Pp 7960-7970 (2011)
Multiple sclerosis (MS) is the prototypical inflammatory demyelinating disorder of the central nervous system (CNS). Although many advances have been made in the comprehension of its pathogenesis, the etiology is still unknown. The complexity of MS r
Externí odkaz:
https://doaj.org/article/bc59687c857b4d34ad70d3e4bd11bc03
Autor:
Massimiliano Calabrese, Richard Reynolds, Roberta Magliozzi, Marco Castellaro, Aldo Morra, Antonio Scalfari, Gabriele Farina, Chiara Romualdi, Alberto Gajofatto, Marco Pitteri, Maria Donata Benedetti, Salvatore Monaco
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135428 (2015)
Both gray-matter (GM) atrophy and lesions occur from the earliest stages of Multiple Sclerosis (MS) and are one of the major determinants of long-term clinical outcomes. Nevertheless, the relationship between focal and diffuse GM damage has not been
Externí odkaz:
https://doaj.org/article/635159500036462d92d4c742db226fb7
Autor:
Luca Massacesi, Irene Tramacere, Salvatore Amoroso, Mario A Battaglia, Maria Donata Benedetti, Graziella Filippini, Loredana La Mantia, Anna Repice, Alessandra Solari, Gioacchino Tedeschi, Clara Milanese
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e113371 (2014)
For almost three decades in many countries azathioprine has been used to treat relapsing-remitting multiple sclerosis. However its efficacy was usually considered marginal and following approval of β interferons for this indication it was no longer
Externí odkaz:
https://doaj.org/article/67a0c72a38ed4c8fa98631028489a6ed
Autor:
Sonia Di Tella, Antonio Marangi, Alessia d’Arma, Laura Mendozzi, Marco Turatti, Milena Sant, Loredana La Mantia, Roberto Lillini, Marco Rovaris, Maria Donata Benedetti, Domenico Caputo
Publikováno v:
Neurological Sciences. 42:5157-5163
The risk of malignancy associated with sequential disease-modifying therapies (DMTs) for patients with multiple sclerosis (MS) is uncertain. The aim of this study was to analyze the risk of cancer in patients with MS treated with azathioprine (AZA) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c23f1d841b69d82e62b5856f8a00da
https://doi.org/10.1007/s10072-021-05216-z
https://doi.org/10.1007/s10072-021-05216-z
Autor:
Domenico Ippolito, Giorgia Teresa Maniscalco, Damiano Paolicelli, Daniele Spitaleri, Francesco Patti, Gianfranco Costantino, Margherita Russo, Clara Grazia Chisari, Letizia Castelli, Giovanna Salamone, Roberto Bruno Bossio, Maria Trotta, Claudio Solaro, Eliana Berra, Roberta Lanzillo, Elisabetta Signoriello, Raffaella Cerqua, Isabella Righini, Fabio Buttari, Gabriella Spinicci, Loredana Petrucci, Angelica Guareschi, Manuela Matta, Mario Zappia, Simona Pontecorvo, Maria Donata Benedetti, Paola Cavalla, Assunta Bianco, Claudio Gasperini, Eleonora Tavazzi, Francesco Saccà, Mauro Zaffaroni
Publikováno v:
Neurological Sciences. 41:2905-2913
Introduction: The approval of 9-δ-tetrahydocannabinol (THC)+cannabidiol (CBD) oromucosal spray (Sativex®) in Italy as an add-on medication for the management of moderate to severe spasticity in multiple sclerosis (MS) has provided a new opportunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd9f3855c640f0921c03963b4dac58be
https://doi.org/10.1007/s10072-020-04413-6
https://doi.org/10.1007/s10072-020-04413-6
Autor:
Daniele Velardo, Sara Meoni, Valeria Isella, Nicolaja Girone, Delfina Tosi, Alessandro Innocenti, Orsola Gambini, Francesca Bai, Maria Paola Canevini, Chiara Manfredi, Roberta Ferrucci, Tommaso Bocci, Gaetano Bulfamante, Carlo Ferrarese, Paola Alberti, Beatrice Benatti, Laura Campiglio, Alessandro Padovani, Alessandro Pezzini, Gemma Tumminelli, Alberto Benussi, Elio Clemente Agostoni, Veronica Nisticò, Giulia Michela Pellegrino, Maria Donata Benedetti, Vincenzo Silani, Giacomo P. Comi, Simone Beretta, Gianluca Costamagna, Laura Bertolasi, Valentina Chiesa, Andrea Pilotto, Chiara Vannicola, Giuseppe Francesco Sferrazza Papa, Luca Valvassori, Fabrizio Luiso, Michelangelo Dini, Valentina Toto, Carla Uggetti, Alberto Priori, Elena Moro, Davide Chiumello, Stefano Centanni, Giulia Marchetti, Francesca Lanzani, Benedetta Demartini, Emma Scelzo, Matteo Bonifazi, Laura Carpenito, Laura Brighina, Ilaria Viganò, Marco Scarabello, Roberta Rovito, Antonella d'Arminio Monforte, Angelo Cascio Rizzo, Elisabetta De Bernardi, Giuditta Giussani, Bernardo Dell'Osso
The authors will present a comprehensive account of the neurological aspects of SARS-CoV-2 infection. The aim is to provide a practical clinical book which will serve as a guide for clinicians from all specialties involved in the management of COVID-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::722837836b9fa4f7f8eb71e2a6e85b35
https://doi.org/10.54103/milanoup.57
https://doi.org/10.54103/milanoup.57
